Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) posted quarterly Total Current Liabilities of $10.4 million for Q1 2026, up 6.98% year-on-year from $9.8 million in Q1 2025, and down 0.56% on a QoQ basis from $10.5 million in Q4 2025.
Alpha Tau Medical (DRTS) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Total Current Liabilities for 7 consecutive years, with $10.4 million the latest figure, recorded in Q1 2026.
- Quarterly Total Current Liabilities rose 6.98% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 6.98% YoY) and the FY2025 annual result came in at $10.5 million, up 21.12% from the prior year.
- Total Current Liabilities eased to $10.4 million in Q1 2026 per DRTS's latest filing, from $10.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for DRTS reached as high as $10.5 million in Q4 2025 and fell as low as $2.8 million in Q2 2022.
- A 5-year average of $6.9 million and a median of $6.5 million in 2024 frame the typical range for Total Current Liabilities.
- The largest YoY upside for Total Current Liabilities was 95.95% in 2023 against a maximum downside of 15.36% in 2023.
- Year by year, Total Current Liabilities stood at $4.3 million in 2022, then soared by 63.72% to $7.1 million in 2023, then increased by 22.15% to $8.7 million in 2024, then rose by 21.12% to $10.5 million in 2025, then slipped by 0.56% to $10.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $10.4 million, $10.5 million, and $9.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Alpha Tau Medical | 1.19 Bn | 1.11 Bn | - | 10.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.45 Mn |
| Dec 31, 2025 | 10.51 Mn |
| Sep 30, 2025 | 9.14 Mn |
| Jun 30, 2025 | 8.16 Mn |
| Mar 31, 2025 | 9.77 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | 6.46 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 6.24 Mn |
| Jun 30, 2023 | 5.42 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 4.34 Mn |
| Sep 30, 2022 | 3.35 Mn |
| Jun 30, 2022 | 2.76 Mn |
| Mar 31, 2022 | 6.30 Mn |
| Dec 31, 2021 | 4.41 Mn |
| Dec 31, 2020 | 2.09 Mn |